Aim: The GreenBladder study aims at screening all adults more than 40 years old in Greenland for bladder cancer to detect patients with early potentially curable tumor stages. Following treatment, urinary marker follow-up will be used to facilitate regular follow-up in locations with limited availability of urological service. With the early detection and meticulous follow-up, we aim at improving the current very poor prognosis for bladder cancer patients in Greenland.

Number of patients: All citizens of Greenland above the age of 40 years, living in the 13 towns with more than 1.000 citizens, will be invited to a screening visit at the local hospital or health clinic.

Methods:
The screening visit consist of:

• Interview regarding visible hematuria within the last year.

• A short questionnaire on demographics and potential risk factors for development of bladder cancer.

• Urine dipstick.

• Xpert ® Bladder Cancer Detection test. 

If the person investigated fulfills any of the criteria below, he/she will be offered a PrimeSight flexible cystoscopy:

• Visible hematuria within the last year.

• Positive Xpert ® Bladder Cancer Detection test.

Status: We expect to be able to start up in the spring of 2023 and implement our screening visits during 2023-2024 in the 13 cities.

Sites: 
Queen Ingrid´s Hospital
Jens Kreutzmannip aqq 11.
Postbox 1001
3900 Nuuk

Tasiilaq Health Center
Postboks 510
3913 Tasiilaq

Narsaq Health Center
Postbox 32
3921 Narsaq

Qaqortoq Regional Hospital
Postbox 512
3920 Qaqortoq

Paamiut Health Center
Postbox 98
3940 Paamiut

Nanortalik Hospital
Box 169
3922 Nanortalik

Maniitsoq Health Center
Postbox 501
3912 Maniitsoq

Sisimiut Region Hospital
Postbox 1013
3911 Sisimiut

Aassiaat Region Hospital
Postbox 212
3950 Aasiaat

Qasigiannguit Health Center
Postbox 114
3951 Qasigiannguit

Ilulissat Regional Hospital
Postbox 514
3952 Ilulissat

Uummannaq Health Center
Postbox 191
3961 Uummannaq

Upernavik Health Center
Postbox 64
3962 Upernavik